Capricor Therapeutics Inc (CAPR)

Sector:
REAL ESTATE
Industry:
REAL ESTATE MANAGEMENT & DEVELOPMENT
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Linda Marba¡n
Employees:
18
8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA 90211
(310) 358-3200

Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.

Data derived from most recent annual or quarterly report
Market Cap 74.621 Million Shares Outstanding24.149 Million Avg 30-day Volume 184.612 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.0 EBITDA0
Price to Book Value0.0 Operating Margin0.0 Enterprise Value51.062 Million
Current Ratio13.82 EPS Growth0 Quick Ratio13.666
1 Yr BETA 1.3763 52-week High/Low 8.4 / 2.75 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score0.0 Free Cash Flow to Firm 0
View SEC Filings from CAPR instead.

View recent insider trading info

Funds Holding CAPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAPR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

190.4 Thousand total shares from 3 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUNBAR GEORGE W JR

63,060 2022-01-03 1

COLLIER EARL M JR

63,060 2022-01-03 1

MUSKET DAVID B

84,080 2022-01-03 2

LITVACK FRANK

359,632 2022-01-03 1

MARBAN LINDA CHIEF EXECUTIVE OFFICER

377,830 2022-01-03 1

KRASNEY KAREN EVP, GENERAL COUNSEL

84,080 2022-01-03 1

BERGMANN ANTHONY CHIEF FINANCIAL OFFICER

166,980 2022-01-03 1

MANZO LOUIS

83,590 2022-01-03 1

SABAR KARIMAH ES

7,690 2022-01-03 3

ASCHEIM DEBORAH CHIEF MEDICAL OFFICER

  • Officer
0 2018-07-24 0

KAZAM JOSHUA A

  • Director
0 2018-01-02 0

SMITH RACHEL VICE PRESIDENT OF R&D

  • Officer
0 2018-01-02 0

CEDARS SINAI MEDICAL CENTER

  • 10% Owner
4,049,959 2017-05-09 0

MARBAN EDUARDO

  • 10% Owner
3,307,863 2016-12-31 0

GRASMICK LOUIS J

  • Director
1,182,439 2016-03-16 0

GERSHELL LELAND CHIEF FINANCIAL OFFICER

  • Officer
3,150 2016-03-16 0

ST. JOHN EDWARD A.

EDWARD ST. JOHN, LLC

  • 10% Owner
4,750,185 2016-03-16 0

SCHAFER GREGORY W

  • Director
0 2015-03-03 0

HAMER ANDREW WARWICK VP OF MEDICAL AFFAIRS

  • Officer
0 2015-03-03 0

DAVIES ANTHONY CHIEF TECHNOLOGY OFFICER

  • Officer
0 2013-11-20 0

ST. JOHN EDWARD A.

MD BTI, LLC

EDWARD ST. JOHN, LLC

  • 10% Owner
5,047,221 2013-11-20 0

HORTON DARLENE P PRESIDENT & CEO

  • Officer
  • Director
0 2012-08-06 0

KASH PETER M

  • Director
2,258,327 2011-07-18 0

LIEU HSIAO VP, CLINICAL RESEARCH

  • Officer
100 2011-05-26 0

GRANADILLO PEDRO P

  • Director
27,588 2011-05-10 0

BELLDEGRUN ARIE

  • Director
711,420 2011-05-10 0

MIEYAL PAUL A

  • Director
0 2011-05-10 0

EVANS DARON CHIEF FINANCIAL OFFICER

  • Officer
23,752 2011-04-18 0

BREWER RICHARD B EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2010-07-26 0

TANEN DAVID M

  • Director
No longer subject to file 2009-12-31 0

STRUMPH PETER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2009-01-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LITVACK FRANK

2022-01-04 21:01:02 -0500 2022-01-03 F 67,552 $3.18 d 107,382 direct 0.0 6.689 6.689 6 0.0 1

SABAR KARIMAH ES

2022-01-04 21:00:57 -0500 2022-01-03 A 7,690 a 7,690 direct

COLLIER EARL M JR

2022-01-04 21:00:39 -0500 2022-01-03 A 63,060 a 63,060 direct

MARBAN LINDA CHIEF EXECUTIVE OFFICER

2022-01-04 21:00:12 -0500 2022-01-03 A 377,830 a 377,830 direct

LITVACK FRANK

2022-01-04 21:01:02 -0500 2022-01-03 M 154,543 $1.39 a 174,934 direct 0.0 6.689 6.689 6 0.0 1

LITVACK FRANK

2022-01-04 21:01:02 -0500 2022-01-03 A 252,250 a 252,250 direct

MANZO LOUIS

2022-01-04 21:00:46 -0500 2022-01-03 A 83,590 a 83,590 direct

KRASNEY KAREN EVP, GENERAL COUNSEL

2022-01-04 21:00:20 -0500 2022-01-03 A 84,080 a 84,080 direct

BERGMANN ANTHONY CHIEF FINANCIAL OFFICER

2022-01-04 21:00:26 -0500 2022-01-03 A 166,980 a 166,980 direct

LITVACK FRANK

2022-01-04 21:01:02 -0500 2022-01-03 M 154,543 d 0 direct

MUSKET DAVID B

2022-01-04 21:00:52 -0500 2022-01-03 A 84,080 a 84,080 direct

DUNBAR GEORGE W JR

2022-01-04 21:00:37 -0500 2022-01-03 A 63,060 a 63,060 direct

MUSKET DAVID B

2021-12-29 09:00:15 -0500 2021-12-27 M 15,455 $1.39 a 38,346 direct 2.0408 1.7007 8.1633 4 -0.3401 3

MUSKET DAVID B

2021-12-29 09:00:15 -0500 2021-12-27 M 20,391 d 0 direct

MUSKET DAVID B

2021-12-29 09:00:15 -0500 2021-12-27 M 15,455 d 0 direct

MUSKET DAVID B

2021-12-29 09:00:15 -0500 2021-12-27 M 20,391 $1.10 a 58,737 direct 2.0408 1.7007 8.1633 4 -0.3401 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 22:15:04 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 21:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 21:15:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 20:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 20:15:04 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 19:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 19:15:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 18:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 18:15:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 17:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 17:15:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 16:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 16:15:04 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 15:45:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 15:15:03 UTC -5.8953 5.9653 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 14:45:03 UTC -5.7324 5.8024 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 14:15:03 UTC -5.7324 5.8024 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 13:45:03 UTC -5.7324 5.8024 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 13:15:03 UTC -5.7324 5.8024 1100000
CAPRICOR THERAPEUTICS INC CAPR 2022-01-17 12:45:03 UTC -5.7324 5.8024 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CAPR -5358.0 shares, $-21539.16 2021-09-30 N-PORT

Elevate your investments